What's New in U.S. HIV Clinical Treatment Guidelines
The latest update to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV occurred within the perinatal HIV prevention guidelines on Dec. 20.
Featured
This San Francisco Clinic Is Rethinking Care for People Living With HIV Experiencing Homelessness
The results: 79% of enrolled participants restarted their antiretroviral therapy within a week of enrolling, and 55% were virally suppressed after six months.
Where Does the Science Stand on COVID-19 Outcomes Among People Living With HIV?
The worst fears about HIV and COVID-19 don’t appear to have materialized, but concerns persist, particularly in cases where HIV treatment efficacy is suboptimal or comorbidities are present.
LGBTQ Health and Well-Being: Where Is the U.S. Right Now?
Tonia Poteat, Ph.D., PA-C, M.P.H., and Marlon M. Bailey, Ph.D., dive into the important takeaways of a major new report on sexual and gender diverse populations in the U.S.
Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters
W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.
Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
Loneliness Linked to Poorer Brain Health and Reduced Quality of Life in HIV
As CATIE reports, a Canadian study found that people living with HIV were more likely to be lonely than the average person—and that loneliness grew more common the younger a person with HIV was.
Are Providers Ignoring Anal Sex as a Health Care Issue for Women at Risk for HIV and Cancer?
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.
Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Newly Diagnosed and Those Already Undetectable
Questions still remain as to when FDA will approve, and how it will be implemented.
New York City Makes Strides in HIV Diagnosis Times, More Work Ahead
Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
When Providers Don't Use Gender-Affirming Language, It Negatively Impacts HIV-Positive Transgender Women's Health
A new study shows that helping clinicians use gender-affirming language is important for transgender women in care. But we need more research on how HIV medications and feminizing hormones interact.